Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03744715 |
| Title | A Study to Allow Continued Treatment of Patients Who Have Participated in a Spectrum-Sponsored Poziotinib Study |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Spectrum Pharmaceuticals, Inc |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Pacific Shores Medical Group | Long Beach | California | 90813 | United States | Details | |
| Hattiesburg Clinic Hematology Oncology | Hattiesburg | Mississippi | 39401 | United States | Details | |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | New York | New York | 10016 | United States | Details | |
| UPMC | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| UT MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |